Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Ulrich

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Metabolites|September 11, 2019
Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare StudyJennifer Ose, Biljana Gigic, Tengda Lin, et al.
Cancer Cell|April 13, 2016
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer PatientsNiels Halama, Inka Zoernig, Anna Berthel, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Oncoimmunology|July 3, 2015
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trialFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, et al.
Lancet (London, England)|September 14, 2017
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trialMarkus K Diener, Felix J Hüttner, Meinhard Kieser, et al.
BMJ Open|December 22, 2022
Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival - the FOCUS ConsortiumBiljana Gigic, Eline van Roekel, Andreana N Holowatyj, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2022
Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer PatientsCaroline Himbert, Christy A Warby, Biljana Gigic, et al.
The British Journal of Nutrition|February 6, 2020
One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare StudyRama Kiblawi, Andreana N Holowatyj, Biljana Gigic, et al.
Lancet (London, England)|April 11, 2014
Effectiveness of triclosan-coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomised controlled PROUD trialMarkus K Diener, Phillip Knebel, Meinhard Kieser, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Metabolites|September 11, 2019
Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare StudyJennifer Ose, Biljana Gigic, Tengda Lin, et al.
Cancer Cell|April 13, 2016
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer PatientsNiels Halama, Inka Zoernig, Anna Berthel, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Oncoimmunology|July 3, 2015
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trialFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, et al.
Lancet (London, England)|September 14, 2017
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trialMarkus K Diener, Felix J Hüttner, Meinhard Kieser, et al.
BMJ Open|December 22, 2022
Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival - the FOCUS ConsortiumBiljana Gigic, Eline van Roekel, Andreana N Holowatyj, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2022
Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer PatientsCaroline Himbert, Christy A Warby, Biljana Gigic, et al.
The British Journal of Nutrition|February 6, 2020
One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare StudyRama Kiblawi, Andreana N Holowatyj, Biljana Gigic, et al.
Lancet (London, England)|April 11, 2014
Effectiveness of triclosan-coated PDS Plus versus uncoated PDS II sutures for prevention of surgical site infection after abdominal wall closure: the randomised controlled PROUD trialMarkus K Diener, Phillip Knebel, Meinhard Kieser, et al.
Pageof 18